Polyphron
Sep 17, 2026 · Seed
Polyphron Raises $20M Seed Round Led by Quiet Capital to Build Artificial Human Biology for Drug Development
Polyphron Secures $20M Seed Funding Polyphron, a New York based biotech company building artificial human biology for drug development, has raised $20 million…
